JL1125ES - JL1125ES: Patient-reported outcomes in patients with metastatic non-squamous non-small cell lung cancer (NSCLC) from the PERLA trial comparing first-line chemotherapy plus dostarlimab or pembrolizumab

Full author listing

Martin Reck, MD, PhD1, Ana Laura Ortega Granados, MD2, Filippo de Marinis, MD3, Oren Meyers, PhD4, Susan Boklage, MS, MPH4, Qin Shen, PhD4, Lillian Cho, PharmD4

1Lungen Clinic, Airway Research Center North, Center for Lung Research, Grosshansdorf, Germany; 2Servicio de Oncología Médica, Hospital Universitario de Jaén, Spain; 3European Institute of Oncology, Milan, Italy; 4GSK, Collegeville, PA, USA